IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Immunoglobulin G Subclass 4 Related Disease
Mayo Clinicmonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Immunoglobulin G Subclass 4 Related Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Leflunomide Chinese PLA General Hospital | Phase 4 | BB |
PREDNISONE TABLETS Chinese PLA General Hospital | Phase 4 | BB |
Filgotinib UMC Utrecht | Phase 2 | CCC |
Bcma-Cd19 Ccar T Cells Peking University People's Hospital | Phase 2 | CCC |
cc-5013 Mayo Clinic | Phase 1 | CC |
Mtm-H-001 Beijing GoBroad Hospital | N/A | D |
Lvivo-Tavec400 Product Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Early Phase 1 | NR |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →